MétaCan
Menu
Back to cohort
Record W4411339637 · doi:10.1016/j.eclinm.2025.103292

Respiratory syncytial virus-attributable hospitalizations among adults in high- and middle-income countries: application of the Global Burden of Disease framework

2025· article· en· W4411339637 on OpenAlexaffabout
Katrin Burkart, Caihua Liang, Quinn Rafferty, Catherine W. Gillespie, Susan McLaughlin, Andrei Oros, Jam Suba, Marion Fahey, Ana Gabriela Grajales, Mariana Haeberer, Caroline Lade, Asuka Yoshida, Bradford D. Gessner, Elizabeth Begier

Bibliographic record

VenueEClinicalMedicine · 2025
Typearticle
Languageen
FieldMedicine
TopicRespiratory viral infections research
Canadian institutionsPfizer (Canada)
FundersPfizer
KeywordsMedicineBurden of diseaseLow and middle income countriesDisease burdenDiseaseRespiratory systemCoronavirus disease 2019 (COVID-19)Environmental healthSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Intensive care medicinePediatricsDeveloping countryInternal medicineInfectious disease (medical specialty)Economic growth

Abstract

fetched live from OpenAlex

Background Respiratory syncytial virus (RSV) in adults is typically underdiagnosed due to non-specific symptoms, infrequent routine testing, and low-test sensitivity; consequently, its impact is not well understood. To address this gap, we developed a novel approach to estimate adult RSV-related hospitalizations, leveraging methods from the Global Burden of Disease (GBD) study. Methods We collected aggregated clinical data from hospital statistics and insurance claims on respiratory and cardiorespiratory hospitalizations and RSV activity proxies for age groups 18–59 years, 60–74 years, ≥60 years, and ≥75 years in 15 countries (Argentina, Brazil, Canada, Chile, Georgia, Germany, Greece, Ireland, Italy, Japan, Mexico, New Zealand, Poland, Spain, and the United States) between 1992 and 2021. In addition, we collected RSV surveillance data, i.e., the percentage of samples tested positive for RSV from the WHO GISRS platform—the Global Influenza Surveillance and Response System and from country-specific reporting platforms for countries from North and South America, Europe and Asia, covering the years 2015–2023. Using the GBD comparative risk assessment framework, we estimated exposure-response relationships between RSV activity and hospitalizations using generalized additive models (GAMs), adjusting for trend, seasonality, meteorological influence and influenza activity, between the years 2015–2019, and calculated the population attributable fraction (PAF) and RSV-attributable hospitalizations. We evaluated the predictive power of surveillance-based versus hospital-based RSV proxies based on adjusted R 2 , and generalized cross-validation (GCV) score. Findings We identified significant relationships (p-value < 0.01) between RSV activity and increased respiratory and cardiorespiratory hospitalizations among adults. Generally, hospital-based RSV proxies predicted hospitalization better than surveillance-based proxies. RSV-attributable hospitalization rates and PAFs varied substantially by age and country. The highest annual RSV-attributable hospitalization rates were estimated for individuals 75 years and older, ranging from 110.9 (95% uncertainty interval [UI]: 66.9–156.1, median: 113.5, inter quartile range [IQR]: 10.4) per 100,000 population in Argentina for respiratory hospitalizations to 1199.8 (1087.0–1313.8, 1209.5, 88.9) per 100,000 in New Zealand for cardiorespiratory hospitalizations. The lowest RSV-attributable hospitalizations, for respiratory and cardiorespiratory diseases, were found for adults aged 18–59 years in Spain with 5.0 (95% UI: 0.8–9.3) hospitalizations per 100,000 for the hospital-based proxy. Interpretation Innovations introduced by this analysis include non-parametric modelling of the exposure-response relationship between RSV activity and hospitalizations and evaluating the predictive reliability of two RSV proxies. Our findings highlight the substantial adult RSV disease burden, provide estimates for countries with no prior data (particularly those in (sub)tropical climates such as Mexico and Brazil), and illustrate the considerable geographic variability in adult RSV incidence. These results can guide future research, interventions, and policy decisions, including those involving adult RSV vaccines. Funding This study was sponsored by Pfizer Inc.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.005
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.007
Threshold uncertainty score0.624

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.005
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.002
Science and technology studies0.0000.001
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.018
GPT teacher head0.363
Teacher spread0.345 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations13
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueEClinicalMedicineSame topicRespiratory viral infections researchFrench-language works237,207